Back to Journals » Cancer Management and Research » Volume 14

Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis [Retraction]

Authors Jia Y, Li S, Zhang M, Zhang Z, Wang C, Zhang C, Yang W, Peng L, Xu Z

Received 19 May 2022

Accepted for publication 19 May 2022

Published 23 May 2022 Volume 2022:14 Pages 1757—1758

DOI https://doi.org/10.2147/CMAR.S375355



Jia Y, Li S, Zhang M, et al. Cancer Manag Res. 2021;13:337—349.

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors have advised the journal they can no longer verify the validity of the reporting findings and cannot provide the original data for their study. To maintain the integrity of the scholarly record the authors requested to retract the article.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.